Minoryx Therapeutics
Contact information
Minoryx Therapeutics
Marc Martinell, CEO
TecnoCampus Mataró-Maresme, Av. Ernest Lluch 32, TCM2
Mataró
Barcelona
935441466
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Screening
- Therapeutic areas
- Genetic and rare diseases
Commissions
At Minoryx, we are committed to finding novel treatments for life threatening rare diseases. We prioritize pediatric diseases and we are currently focused on neurometabolic diseases of genetic origin.
Products and services
Minoryx develops a new generation of non-competitive pharmacological chaperones through a proprietary technological platform. As a complementary approach, Minoryx also progress repositioning-based projects.
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| MIN-102 (leriglitazone) | Biodrugs/ Drugs | Sistema nervioso central | P II |
| MIN-102 (leriglitazone) | Biodrugs/ Drugs | Sistema nervioso central, Trastornos metabólicos / Endocrinología | Registration |
| MIN-102 (leriglitazone) | Biodrugs/ Drugs | Sistema nervioso central, Trastornos metabólicos / Endocrinología | P III |